Generated by DeepSeek V3.2| Moses Chao | |
|---|---|
| Name | Moses Chao |
| Nationality | American |
| Fields | Neuroscience, Molecular biology, Neurotrophic factors |
| Workplaces | New York University School of Medicine, University of California, San Diego, Skirball Institute of Biomolecular Medicine |
| Alma mater | University of California, Los Angeles, University of California, San Diego |
| Known for | Research on nerve growth factor, p75 neurotrophin receptor, cell death signaling |
| Awards | McKnight Endowment Fund for Neuroscience, NIH Director's Pioneer Award |
Moses Chao. He is an American neuroscientist renowned for his pioneering research on neurotrophic factors and their receptors, which are critical for neuronal survival, synaptic plasticity, and neurodegenerative diseases. His work has fundamentally advanced the understanding of cell signaling pathways in the nervous system, particularly focusing on the p75 neurotrophin receptor and its role in regulating apoptosis. Chao's career has been primarily affiliated with major academic institutions including the New York University School of Medicine and the Skirball Institute of Biomolecular Medicine.
Chao completed his undergraduate studies at the University of California, Los Angeles, where he developed an interest in biological sciences. He then pursued his doctoral degree at the University of California, San Diego, earning a PhD in molecular biology. His early academic training provided a strong foundation in gene expression and molecular genetics, which he later applied to neuroscience. This period was influenced by the burgeoning field of neurobiology and seminal discoveries related to growth factors.
Chao began his independent research career with a focus on the mechanisms of nerve growth factor, a prototypical neurotrophin first identified by Rita Levi-Montalcini. He held a faculty position at the University of California, San Diego before moving to the New York University School of Medicine, where he became a professor. A major focus of his laboratory at the Skirball Institute of Biomolecular Medicine has been the p75 neurotrophin receptor, investigating its complex signaling in cell death and neuronal development. His research has elucidated how this receptor interacts with other proteins like sortilin and the Trk receptor family to dictate cellular outcomes. This work has significant implications for understanding Alzheimer's disease, amyotrophic lateral sclerosis, and spinal cord injury.
Throughout his career, Chao has received numerous accolades recognizing his contributions to neuroscience. He is a recipient of a prestigious award from the McKnight Endowment Fund for Neuroscience, which supports innovative research. He has also been honored with the NIH Director's Pioneer Award, part of the National Institutes of Health High-Risk, High-Reward Research program. His election as a fellow to the American Association for the Advancement of Science further underscores his standing in the scientific community. His work is frequently supported by grants from the National Institute of Neurological Disorders and Stroke.
Chao has authored many influential papers in high-impact journals. Key publications include studies on the cloning and characterization of the p75 neurotrophin receptor published in Cell and Science. His work on neurotrophin signaling and apoptosis has appeared in Neuron and the Journal of Neuroscience. Another significant publication explored the role of proNGF in neuronal death, featured in Nature. These articles are widely cited and form a cornerstone of modern neurotrophin research.
Details regarding his personal life are kept private, consistent with his focus on his scientific career and mentorship. He is known within the academic community for training numerous postdoctoral fellows and graduate students who have gone on to establish their own laboratories at institutions like Harvard Medical School and Stanford University. Outside of the laboratory, he has participated in scientific advisory roles for organizations such as the Society for Neuroscience and various biotechnology companies focused on neurological disorders.
Category:American neuroscientists Category:Molecular biologists Category:Living people